May 20, 2020 / 2:45 PM / 6 days ago

BRIEF-Viralclear Closes $10.8 Million Equity Financing For Development Of Covid-19 Broad-Spectrum Oral Anti-Viral Candidate Merimepodib

Biosig Technologies Inc:

* VIRALCLEAR CLOSES $10.8 MILLION EQUITY FINANCING FOR DEVELOPMENT OF COVID-19 BROAD-SPECTRUM ORAL ANTI-VIRAL CANDIDATE MERIMEPODIB Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below